细胞溶解
细胞毒性T细胞
免疫疗法
细胞毒性
穿孔素
CTL公司*
体外
生物
CD8型
癌症研究
颗粒酶B
黑色素瘤
免疫学
免疫系统
化学
生物化学
作者
Yael Gruper,Tali Feferman,Tali Shalit,Tomer‐Meir Salame,Ziv Porat,Guy Shakhar
出处
期刊:Cell Reports
[Elsevier]
日期:2017-09-01
卷期号:20 (11): 2547-2555
被引量:132
标识
DOI:10.1016/j.celrep.2017.08.071
摘要
Cytotoxic T lymphocytes (CTLs) used in immunotherapy are typically cultured under atmospheric O2 pressure but encounter hypoxic conditions inside tumors. Activating CTLs under hypoxic conditions has been shown to improve their cytotoxicity in vitro, but the mechanism employed and the implications for immunotherapy remain unknown. We activated and cultured OT-I CD8 T cells at either 1% or 20% O2. Hypoxic CTLs survived, as well as normoxic ones, in vitro but killed OVA-expressing B16 melanoma cells more efficiently. Hypoxic CTLs contained similar numbers of cytolytic granules and released them as efficiently but packaged more granzyme-B in each granule without producing more perforin. We imaged CTL distribution and motility inside B16-OVA tumors using confocal and intravital 2-photon microscopy and observed no obvious differences. However, mice treated with hypoxic CTLs exhibited better tumor regression and survived longer. Thus, hypoxic CTLs may perform better in tumor immunotherapy because of higher intrinsic cytotoxicity rather than improved migration inside tumors.
科研通智能强力驱动
Strongly Powered by AbleSci AI